Published in Cancer Weekly, July 15th, 2003
Their presentation was at the 85th Annual Meeting of the Endocrine Society at the Pennsylvania Convention Center in Philadelphia.
The presentation highlighted results from a series of preclinical studies using AVI BioPharma's Neugene antisense technology to block the expression of the gene XIAP. In a wide variety of cancers, including...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.